Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-01-30

Clinical Trial Update: Comparison of Eprosartan/HCT Versus Enalapril/HCT in Hypertensives With Type II Diabetes [NA]

View source ↗

Summary

A completed clinical trial comparing eprosartan/hydrochlorothiazide to enalapril/hydrochlorothiazide in hypertensive patients with type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • enalapril/hydrochlorothiazide (enalapril/hydrochlorothiazide)
  • eprosartan/hydrochlorothiazide (eprosartan/hydrochlorothiazide)

Snippet

Sponsor: Solvay Pharmaceuticals | Conditions: Hypertension, Type 2 Diabetes | NA | Status: COMPLETED